Gilead Sciences is pushing full speed ahead with its strategy to ensure global access to its long-acting HIV pre-exposure ...

The Gender Equality Fund Project commenced operations in Lagos State on July 4, 2025 with a Joint Inception Meeting that ...

A five-item tool using spirometry and basic clinical data may predict recurrent tuberculosis with moderate accuracy, helping ...

Lower-income countries, including South Africa, gain unprecedented access to lenacapavir, a revolutionary HIV prevention drug ...

Gilead Sciences, Inc. (GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to combat AIDS, ...

Humans have been getting infected by ancient bacteria and viruses for at least 37,000 years. Now, for the first time, ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Tulane University researchers have developed a new handheld TB test that significantly improves detection in people with HIV, ...